YWHAZ
protein-codingtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta, the group of 14-3-3 phospho-serine/phospho-threonine binding proteins
Gene summary
This gene product belongs to the 14-3-3 family of proteins which mediate signal transduction by binding to phosphoserine-containing proteins. This highly conserved protein family is found in both plants and mammals, and this protein is 99% identical to the mouse, rat and sheep orthologs. The encoded protein interacts with IRS1 protein, suggesting a role in regulating insulin sensitivity. Several transcript variants that differ in the 5' UTR but that encode the same protein have been identified for this gene. [provided by RefSeq, Oct 2008]
- YWHAD
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0700092
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
The *YWHAZ* gene is located on chromosome 8 at 8q22.3 and encodes the tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta protein, which mediates signal transduction by binding to phosphoserine-containing proteins. *YWHAZ* was first reported in relation to autosomal dominant complex neurodevelopmental disorder in 2019 (Popov et al., PMID:31024343). Seven variants (missense, nonsense, and frameshift) that have been reported in 7 probands in 3 publications are included in this curation (PMIDs: 31024343, 23999528, 36001342, 35143101). This gene-disease relationship is also supported by experimental evidence including animal models that suggest that this gene contributes to neurobehavioral deficits, and plays a role in establishing neuronal connectivity and modulating neurotransmission (PMIDs: 35501409, 22124272, 26207352). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date August 15, 2025 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Illumina
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dermatologic; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to YWHAZ variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_145690.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 10 | 3 | 14 | ||
| missense | 3 | 3 | 10 | 1 | 17 | |
| nonsense | 1 | 2 | 3 | |||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | 3 | 5 | ||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 5 | 4 | 21 | 10 | 4 | 44 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_663723.1 | 5 | MANE Select | |
| Ensembl | ENSP00000379288.2 | 5 | MANE Select | |
| RefSeq | NP_001129171.1 | 5 | Standard | |
| RefSeq | NP_001129172.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- PI3K-Akt signaling pathway - Homo sapiens (human)
- Cell cycle - Homo sapiens (human)
- Oocyte meiosis - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Pathogenic Escherichia coli infection - Homo sapiens (human)
Biological Process
- protein targeting
- signal transduction
- synaptic target recognition
- cytokine-mediated signaling pathway
- platelet activation
Molecular Function
- RNA binding
- protein binding
- transcription factor binding
- protein kinase binding
- protein domain specific binding
Cellular Component
- extracellular space
- nucleus
- nucleoplasm
- cytoplasm
- mitochondrion
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000395957
- Coding exons
- 5
- Length
- 36864
- Individuals with no LoFs
- 124788
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124789
- p
- 0.00000401
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.10 | 30 | 129 | 0.233 | 0.00000649 | 1594 |
| Missense (PolyPhen) | 2 | 41.16 | 0.048591 | 610 | ||
| Synonymous | 0.168 | 48 | 49.5 | 0.970 | 0.00000276 | 437 |
| Loss of Function | 3.13 | 1 | 13.3 | 0.0752 | 6.46e-7 | 169 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000088 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. {ECO:0000269|PubMed:14578935, ECO:0000269|PubMed:15071501, ECO:0000269|PubMed:15644438, ECO:0000269|PubMed:16376338, ECO:0000269|PubMed:9360956}.;
Recessive Scores
- pRec
- 0.586
Intolerance Scores
- LoFtool
- 0.410
- RVIS EVS
- 0.08
- RVIS percentile EVS
- 59.43
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.991
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Low | Low | Low |
| Primary Immunodeficiency | Low | Low | Low |
| Cancer | Low | Low | Low |